Tag: partnerships

  • HLTH Europe 2026 – Amsterdam

    HLTH Europe 2026 – Amsterdam

    by

    Is Diagnostics at the Table? HLTH Europe 2026 offers a useful test of diagnostics’ position within the wider transformation of healthcare. The programme is built around many of the questions currently shaping care delivery: artificial intelligence, interoperability, health-data infrastructure, prevention, evidence generation, clinical implementation, and the redesign of patient pathways. Diagnostics is indispensable to each…

  • MedTech Forum 2026 – Stockholm

    MedTech Forum 2026 – Stockholm

    by

    When Competitiveness Became the Main Signal The MedTech Forum 2026 produced an unusually clear signal. Across three days of sessions and professional exchanges in Stockholm, discussions repeatedly returned to a concern extending beyond regulation alone: whether Europe can maintain the industrial conditions required to convert medical innovation into sustainable scale. MDR and IVDR remained important,…

  • health.tech global summit 2026

    health.tech global summit 2026

    by

    When Innovation Became a Partnership Question Healthcare innovation is abundant. Converting it into sustained adoption remains more difficult. That distinction became increasingly visible at health.tech global summit 2026 in Basel. Across a large and energetic gathering of startups, corporates, investors, advisors, institutional actors, and international delegations, innovation appeared in many forms: artificial intelligence, digital platforms,…

  • DxPx Europe 2026

    DxPx Europe 2026

    by

    Fast Contacts, Serious Projects, and the Search for the Right Partners DxPx Europe 2026 was my first direct exposure to this particular diagnostics, biotools, precision-medicine, and digital-health partnering environment. It was also a useful reminder that the quality of an industry event is not determined only by the speakers or the formal agenda. It depends…

  • The Book – INSIGHT 5

    The Book – INSIGHT 5

    by

    Strategy in Diagnostics Is Selection Under Constraint. The central question is not which opportunity appears most attractive. It is which exposure the organisation is prepared to inhabit. Why does this matter now? Diagnostics strategy is often presented as a search for opportunity. Which technology should be developed? Which market should be entered? Which partnership should…